Paul Rivard - Chief Legal Officer at TNF Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Stock Symbol
TNFA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul Rivard since 9/13/2023

Holdings reported by Paul Rivard for TNF Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 400K $444K $1.11 Aug 24, 2023 Direct

Transactions reported by Paul Rivard for TNF Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.